Interestingly, encouraging results were obtained in combination with anti-cancer drugs, immune checkpoint inhibitors or vaccines, in terms of increased levels of circulating CD56bright NK cells in ALT-803-treated patients. The gene discussed is GPT; the disease is cancer.